Genomictree Inc. (KOSDAQ:228760)

Genomictree Statistics

Total Valuation

Genomictree has a market cap or net worth of KRW 295.01 billion. The enterprise value is 203.56 billion.

Market Cap	295.01B
Enterprise Value	203.56B

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Genomictree has 24.00 million shares outstanding. The number of shares has increased by 7.07% in one year.

Current Share Class	24.00M
Shares Outstanding	24.00M
Shares Change (YoY)	+7.07%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	16.02%
Owned by Institutions (%)	1.03%
Float	20.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	123.23
PB Ratio	2.43
P/TBV Ratio	2.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-19.38
EV / Sales	85.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.34

Financial Position

The company has a current ratio of 20.48, with a Debt / Equity ratio of 0.02.

Current Ratio	20.48
Quick Ratio	20.26
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.14
Interest Coverage	-49.74

Financial Efficiency

Return on equity (ROE) is -8.65% and return on invested capital (ROIC) is -7.59%.

Return on Equity (ROE)	-8.65%
Return on Assets (ROA)	-7.30%
Return on Invested Capital (ROIC)	-7.59%
Return on Capital Employed (ROCE)	-12.30%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	7.45

Taxes

In the past 12 months, Genomictree has paid 1.09 million in taxes.

Income Tax	1.09M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.75% in the last 52 weeks. The beta is 0.05, so Genomictree's price volatility has been lower than the market average.

Beta (5Y)	0.05
52-Week Price Change	-43.75%
50-Day Moving Average	13,974.80
200-Day Moving Average	16,768.40
Relative Strength Index (RSI)	35.33
Average Volume (20 Days)	118,867

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genomictree had revenue of KRW 2.39 billion and -10.50 billion in losses. Loss per share was -432.67.

Revenue	2.39B
Gross Profit	-628.10M
Operating Income	-15.16B
Pretax Income	-10.63B
Net Income	-10.50B
EBITDA	-13.95B
EBIT	-15.16B
Loss Per Share	-432.67

Balance Sheet

The company has 93.99 billion in cash and 2.15 billion in debt, giving a net cash position of 91.84 billion or 3,826.06 per share.

Cash & Cash Equivalents	93.99B
Total Debt	2.15B
Net Cash	91.84B
Net Cash Per Share	3,826.06
Equity (Book Value)	121.59B
Book Value Per Share	5,052.18
Working Capital	90.82B

Cash Flow

In the last 12 months, operating cash flow was -12.95 billion and capital expenditures -2.31 billion, giving a free cash flow of -15.26 billion.

Operating Cash Flow	-12.95B
Capital Expenditures	-2.31B
Free Cash Flow	-15.26B
FCF Per Share	-635.85

Margins

Gross Margin	-26.24%
Operating Margin	-633.39%
Pretax Margin	-444.02%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genomictree does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.07%
Shareholder Yield	n/a
Earnings Yield	-3.56%
FCF Yield	-5.17%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 14, 2018. It was a forward split with a ratio of 2.

Last Split Date	Sep 14, 2018
Split Type	Forward
Split Ratio	2

Scores

Genomictree has an Altman Z-Score of 43.59 and a Piotroski F-Score of 3.

Altman Z-Score	43.59
Piotroski F-Score	3